UbcH9, Dominant Negative

貨號 Cat. No.
E2-646
規格 Size
100 μg
品牌 Brand
Boston Biochem

Description

UbcH9, Dominant Negative

Catalog #: E2-646




UbcH9, Dominant Negative






Product Source: 

human recombinant



UbcH9 is a member of the E2 family and is homologous to ubiquitin-conjugating enzymes, but is specific for the conjugation of SUMO to a variety of target proteins. This E2 is unusual in that it interacts directly with protein substrates that are modified by SUMOylation, and may play a role in substrate recognition. UbcH9 can mediate the conjugation of all SUMOs to a variety of proteins including RanGAP1, IκBα, and PML without the requirement of an E3 ligase. This enzyme has a mutation of the active site from cysteine to serine which abolishes the ability of UbcH9 to transfer ubiquitin to an accepting E3 protein. Ideal for use as a negative or competitive control, or to study protein-protein interactions.


Product Information



Quantity: 

100 μg






Stock: 

X mg/ml (X μM) in 50 mM HEPES pH 7.6, 125 mM NaCl, 10% glycerol, 1 mM DTT. Actual concentration will vary with specific lot number.






MW: 

20 kDa






Purity: 

> 95% by SDS-PAGE




 


Use & Storage



Use: 

Typical enzyme concentration to support conjugation in vitro is 100 nM-1 μM depending on conditions.






Storage: 

Store at -80°C. Avoid multiple freeze/thaw cycles.



詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢